A marine pigment is being proposed to help radiation work better in glioblastoma
Original title: Prodigiosin in glioblastoma: mechanistic pharmacology and rationale for its development as a radiosensitiser.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is an early idea based on lab work, with no tests in people and no tests with radiation yet.
The short version
This is a review of lab science about a sea-derived compound that might one day make radiation more effective, but it has not been tested with radiation yet.
What was studied. This was a review paper, not a new experiment. The authors looked at why glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary resists radiation, then examined lab research on prodigiosin, a red pigment made by marine bacteria.
What they found. glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary resists radiation for several reasons. Low oxygen in the tumor, changes in how tumor cells make energy, strong DNA repair, and tumor stem cells that survive treatment all play a part. In lab studies, prodigiosin harmed glioblastoma cells in several ways at once, and some of those ways line up with the reasons tumors resist radiation. The authors also noted that no study has yet tested prodigiosin together with radiation.
What this means, and what it doesn't
What it could mean: For now this means scientists have an idea worth testing. The paper lays out a plan for future lab and animal studies. It does not change any treatment a patient can get today.
What it doesn't mean: This does not mean prodigiosin is a treatment. It has not been tested in people, and it has not even been tested with radiation in the lab. The authors also point out it may be hard to get the compound past the barrier that protects the brain. This is an early idea, not a proven therapy, and it is not a promise of a cure.
Source: PubMed, June 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.